Диссертация (Изучение роли последовательностей, богатых аспарагином и глутамином, в индукции амилоидогенеза у дрожжей saccharomyces cerevisiae), страница 19
Описание файла
Файл "Диссертация" внутри архива находится в папке "Изучение роли последовательностей, богатых аспарагином и глутамином, в индукции амилоидогенеза у дрожжей saccharomyces cerevisiae". PDF-файл из архива "Изучение роли последовательностей, богатых аспарагином и глутамином, в индукции амилоидогенеза у дрожжей saccharomyces cerevisiae", который расположен в категории "". Всё это находится в предмете "биология" из Аспирантура и докторантура, которые можно найти в файловом архиве СПбГУ. Не смотря на прямую связь этого архива с СПбГУ, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата биологических наук.
Просмотр PDF-файла онлайн
Текст 19 страницы из PDF
1989. V. 39. (11). P. 1453–61.98. Gibbs C.J., Gajdusek D.C., Asher D.M., Alpers M.P., Beck E., Daniel P.M.,Matthews W.B. Creutzfeldt-Jakob disease (spongiform encephalopathy):transmission to the chimpanzee. // Science. 1968. V. 161. (3839). P. 388–9.99. Glenner G.G., Eanes E.D., Bladen H.A., Linke R.P., Termine J.D.
Beta-pleatedsheet fibrils. A comparison of native amyloid with synthetic protein fibrils. // J.Histochem. Cytochem. 1974. V. 22. (12). P. 1141–58.118100. Glenner G.G., Terry W., Harada M., Isersky C., Page D. Amyloid fibrilproteins: proof of homology with immunoglobulin light chains by sequenceanalyses. // Science.
1971. V. 172. (3988). P. 1150–1.101. Goedert M., Clavaguera F., Tolnay M. The propagation of prion-like proteininclusions in neurodegenerative diseases // Trends Neurosci. 2010. V. 33. (7). P.317–325.102. Goedert M., Spillantini M.G., Tredici K. Del, Braak H.
100 years of Lewypathology // Nat. Rev. Neurol. 2012. V. 9. (1). P. 13–24.103. Goldsbury C., Goldie K., Pellaud J., Seelig J., Frey P., Müller S.A., Kistler J.,Cooper G.J.S., Aebi U. Amyloid Fibril Formation from Full-Length andFragments of Amylin // J. Struct. Biol. 2000a. V. 130.
(2–3). P. 352–362.104. Goldsbury C.S., Wirtz S., Müller S.A., Sunderji S., Wicki P., Aebi U., Frey P.Studies on the in Vitro Assembly of Aβ 1–40: Implications for the Search for AβFibril Formation Inhibitors // J. Struct. Biol. 2000b. V. 130. (2–3). P. 217–231.105. Goldschmidt L., Teng P.K., Riek R., Eisenberg D. Identifying the amylome,proteins capable of forming amyloid-like fibrils. // Proc. Natl. Acad. Sci. U.
S. A.2010. V. 107. (8). P. 3487–92.106. Greenwald J., Riek R. Biology of Amyloid: Structure, Function, and Regulation// Structure. 2010. V. 18. (10). P. 1244–1260.107. Griffith J.S. Self-replication and scrapie. // Nature. 1967. V. 215. (5105). P.1043–4.108. Guillot-Sestier M.-V., Sunyach C., Druon C., Scarzello S., Checler F. Thealpha-secretase-derived N-terminal product of cellular prion, N1, displaysneuroprotective function in vitro and in vivo.
// J. Biol. Chem. 2009. V. 284. (51).P. 35973–86.109. Guyonnet B., Egge N., Cornwall G.A. Functional amyloids in the mouse spermacrosome. // Mol. Cell. Biol. 2014. V. 34. (14). P. 2624–34.110. Hadlow J.W. Scrapie and Kuru // The Lancet1. 1959. V. 274. P. 289–290.119111. Haigh C.L., Edwards K., Brown D.R. Copper binding is the governingdeterminant of prion protein turnover. // Mol. Cell. Neurosci. 2005.
V. 30. (2). P.186–96.112. Halfmann R., Alberti S., Krishnan R., Lyle N., O’Donnell C.W., King O.D.,Berger B., Pappu R. V, Lindquist S. Opposing effects of glutamine and asparaginegovern prion formation by intrinsically disordered proteins. // Mol. Cell. 2011. V.43. (1). P. 72–84.113.
Hamodrakas S.J. Protein aggregation and amyloid fibril formation predictionsoftware from primary sequence: towards controlling the formation of bacterialinclusion bodies // FEBS J. 2011. V. 278. (14). P. 2428–2435.114. Hanahan, D. Techniques for transformation of E. coli // In: Glover D M, editor.DNA cloning: a practical approach. Vol. 1. Oxford, United Kingdom: IRL Press., 1985.
P. 109–135.115. Hanssen O. Ein Beitrag zur Chemie der amyloiden Entartung // Biochem. 1908.V. 13. P. 185–198.116. Harrison P.M., Gerstein M. A method to assess compositional bias in biologicalsequences and its application to prion-like glutamine/asparagine-rich domains ineukaryotic proteomes. // Genome Biol. 2003. V.
4. (6). P. R40.117. Hasler M., Hothorn L.A. Multiple contrast tests in the presence ofheteroscedasticity. // Biom. J. 2008. V. 50. (5). P. 793–800.118. Hernández F., Avila J. The role of glycogen synthase kinase 3 in the early stagesof Alzheimers’ disease // FEBS Lett. 2008. V. 582.
(28). P. 3848–3854.119. Heschl R. Eine hubsche a vista-Reaktion auf amyloid degenerirte Gewebe //Wien Med Wschr. 1875. V. 25. P. 715–716.120. Hobbs J.R., Morgan A.D. Fluorescent Microscopy with Thioflavine-T in theDiagnosis of Amyloid. // J. Pathol.
Bacteriol. 1963. V. 86. P. 437–42.121. Hornshaw M.P., McDermott J.R., Candy J.M. Copper binding to the N-terminaltandem repeat regions of mammalian and avian prion protein. // Biochem.Biophys. Res. Commun. 1995. V. 207. (2). P. 621–9.120122. Hosoda N., Kobayashi T., Uchida N., Funakoshi Y., Kikuchi Y., Hoshino S.,Katada T. Translation termination factor eRF3 mediates mRNA decay throughthe regulation of deadenylation. // J. Biol. Chem. 2003. V.
278. (40). P. 38287–91.123. Hou X., Aguilar M.-I., Small D.H. Transthyretin and familial amyloidoticpolyneuropathy // FEBS J. 2007. V. 274. (7). P. 1637–1650.124. Hutter G., Heppner F.L., Aguzzi A. No Superoxide Dismutase Activity ofCellular Prion Protein in vivo // Biol. Chem. 2003. V. 384. (9).125. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H.,Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., AdamsonJ., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., Graaff E. de,Heutink P., et al. Association of missense and 5’-splice-site mutations in tau withthe inherited dementia FTDP-17.
// Nature. 1998. V. 393. (6686). P. 702–5.126. Iconomidou V.A., Vriend G., Hamodrakas S.J. Amyloids protect the silkmothoocyte and embryo. // FEBS Lett. 2000. V. 479. (3). P. 141–5.127. Inoue H., Nojima H., Okayama H. High efficiency transformation ofEscherichia coli with plasmids // Gene. 1990. V. 96. (1). P. 23–28.128. Invernizzi G., Papaleo E., Sabate R., Ventura S. Protein aggregation:Mechanisms and functional consequences // Int. J. Biochem. Cell Biol. 2012.
V.44. (9). P. 1541–1554.129. Iqbal K., Liu F., Gong C.-X., Alonso A.D.C., Grundke-Iqbal I. Mechanisms oftau-induced neurodegeneration. // Acta Neuropathol. 2009. V. 118. (1). P. 53–69.130. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y.Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specificA beta monoclonals: evidence that an initially deposited species is A beta 42(43).// Neuron. 1994.
V. 13. (1). P. 45–53.131. Jimenez J.L., Nettleton E.J., Bouchard M., Robinson C. V., Dobson C.M.,Saibil H.R. The protofilament structure of insulin amyloid fibrils // Proc. Natl.Acad. Sci. 2002. V. 99. (14). P. 9196–9201.121132. Jurgens R. Eine neue Reaktion auf Amyloidkorper // Virchows Arch PatholAnat Physiol. 1875. V. 65.
P. 189–196.133. Kajava A. V, Baxa U., Steven A.C. Beta arcades: recurring motifs in naturallyoccurring and disease-related amyloid fibrils. // FASEB J. 2010. V. 24. (5). P.1311–9.134. Klunk W.E., Pettegrew J.W., Abraham D.J. Quantitative evaluation of congored binding to amyloid-like proteins with a beta-pleated sheet conformation. // J.Histochem. Cytochem. 1989.
V. 37. (8). P. 1273–81.135. Kruskal W.H., Wallis W.A. Use of Ranks in One-Criterion Variance Analysis// J. Am. Stat. Assoc. 1952. V. 47. (260). P. 583–621.136. Kryndushkin D., Pripuzova N., Burnett B.G., Shewmaker F. Non-targetedidentification of prions and amyloid-forming proteins from yeast and mammaliancells. // J. Biol. Chem. 2013.
V. 288. (38). P. 27100–11.137. Kryndushkin D.S., Alexandrov I.M., Ter-Avanesyan M.D., Kushnirov V. V.Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmentedby Hsp104. // J. Biol. Chem. 2003. V. 278. (49). P. 49636–49643.138. Kushnirov V. V., Alexandrov I.M., Mitkevich O. V., Shkundina I.S., TerAvanesyan M.D.
Purification and analysis of prion and amyloid aggregates //Methods. 2006. V. 39. (1). P. 50–55.139. Kushnirov V. V, Ter-Avanesyan M.D. Structure and replication of yeast prions.// Cell. 1998. V. 94. (1). P. 13–6.140. Kyle R.A. Amyloidosis: A convoluted story // Br. J.
Haematol. 2001. V. 114.(3). P. 529–538.141. Lacroute F. Non-Mendelian mutation allowing ureidosuccinic acid uptake inyeast. // J. Bacteriol. 1971. V. 106. (2). P. 519–522.142. Lansbury P.T., Costa P.R., Griffiths J.M., Simon E.J., Auger M., HalversonK.J., Kocisko D.A., Hendsch Z.S., Ashburn T.T., Spencer R.G. Structural modelfor the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheetcomprising a C-terminal peptide. // Nat.
